Osman I - Search Results

1

Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression.

Rose AE, Poliseno L, Wang J, Clark M, Pearlman A, Wang G, Vega Y Saenz de Miera EC, Medicherla R, Christos PJ, Shapiro R, Pavlick A, Darvishian F, Zavadil J, Polsky D, Hernando E, Ostrer H, Osman I. Rose AE, et al. Among authors: osman i. Cancer Res. 2011 Apr 1;71(7):2561-71. doi: 10.1158/0008-5472.CAN-10-2958. Epub 2011 Feb 22. Cancer Res. 2011. PMID: 21343389 Free PMC article.

2

Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation.

Wu RL, Osman I, Wu XR, Lu ML, Zhang ZF, Liang FX, Hamza R, Scher H, Cordon-Cardo C, Sun TT. Wu RL, et al. Among authors: osman i. Cancer Res. 1998 Mar 15;58(6):1291-7. Cancer Res. 1998. PMID: 9515818

3

HDM2 protein overexpression, but not gene amplification, is related to tumorigenesis of cutaneous melanoma.

Polsky D, Bastian BC, Hazan C, Melzer K, Pack J, Houghton A, Busam K, Cordon-Cardo C, Osman I. Polsky D, et al. Among authors: osman i. Cancer Res. 2001 Oct 15;61(20):7642-6. Cancer Res. 2001. PMID: 11606406

4

HER-2 profiling and targeting in prostate carcinoma.

Morris MJ, Reuter VE, Kelly WK, Slovin SF, Kenneson K, Verbel D, Osman I, Scher HI. Morris MJ, et al. Among authors: osman i. Cancer. 2002 Feb 15;94(4):980-6. Cancer. 2002. PMID: 11920466 Free article. Clinical Trial.

5

Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma.

Hazan C, Melzer K, Panageas KS, Li E, Kamino H, Kopf A, Cordon-Cardo C, Osman I, Polsky D. Hazan C, et al. Among authors: osman i. Cancer. 2002 Aug 1;95(3):634-40. doi: 10.1002/cncr.10685. Cancer. 2002. PMID: 12209757 Free article.

6

HDM2 protein overexpression and prognosis in primary malignant melanoma.

Polsky D, Melzer K, Hazan C, Panageas KS, Busam K, Drobnjak M, Kamino H, Spira JG, Kopf AW, Houghton A, Cordon-Cardo C, Osman I. Polsky D, et al. Among authors: osman i. J Natl Cancer Inst. 2002 Dec 4;94(23):1803-6. doi: 10.1093/jnci/94.23.1803. J Natl Cancer Inst. 2002. PMID: 12464652

7

Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients.

Drobnjak M, Melamed J, Taneja S, Melzer K, Wieczorek R, Levinson B, Zeleniuch-Jacquotte A, Polsky D, Ferrara J, Perez-Soler R, Cordon-Cardo C, Pagano M, Osman I. Drobnjak M, et al. Among authors: osman i. Clin Cancer Res. 2003 Jul;9(7):2613-9. Clin Cancer Res. 2003. PMID: 12855638

8

Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues.

Gorden A, Osman I, Gai W, He D, Huang W, Davidson A, Houghton AN, Busam K, Polsky D. Gorden A, et al. Among authors: osman i. Cancer Res. 2003 Jul 15;63(14):3955-7. Cancer Res. 2003. PMID: 12873990

9

Altered N-myc downstream-regulated gene 1 protein expression in African-American compared with caucasian prostate cancer patients.

Caruso RP, Levinson B, Melamed J, Wieczorek R, Taneja S, Polsky D, Chang C, Zeleniuch-Jacquotte A, Salnikow K, Yee H, Costa M, Osman I. Caruso RP, et al. Among authors: osman i. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):222-7. doi: 10.1158/1078-0432.ccr-0604-3. Clin Cancer Res. 2004. PMID: 14734473

10

Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients.

Osman I, Kang M, Lee A, Deng FM, Polsky D, Mikhail M, Chang C, David DA, Mitra N, Wu XR, Sun TT, Bajorin DF. Osman I, et al. Int J Cancer. 2004 Oct 10;111(6):934-9. doi: 10.1002/ijc.20366. Int J Cancer. 2004. PMID: 15300806

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters